Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Tongling Jieya Biologic Technology
301108
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 64.51%300.91M | 12.34%1.13B | 17.07%781.33M | 11.14%482.16M | -17.10%182.91M | 25.66%1.01B | 27.40%667.4M | 20.51%433.84M | 31.61%220.64M | -11.72%799.76M |
Refunds of taxes and levies | 8.86%26.13M | 11.66%86.05M | 27.57%71.47M | 20.75%48.38M | -13.61%24.01M | 7.41%77.06M | 6.73%56.03M | 17.27%40.07M | 99.81%27.79M | 21.43%71.74M |
Cash received relating to other operating activities | 108.57%9.31M | 110.56%66.5M | -11.49%13.42M | -45.54%7.86M | -78.74%4.47M | 123.24%31.58M | 58.65%15.16M | 87.55%14.44M | 358.87%21M | 5.92%14.15M |
Cash inflows from operating activities | 59.12%336.35M | 15.08%1.28B | 17.28%866.22M | 10.25%538.4M | -21.54%211.39M | 25.74%1.11B | 26.06%738.58M | 21.52%488.35M | 44.75%269.43M | -9.48%885.65M |
Goods services cash paid | 85.23%274.83M | 18.88%647.2M | 43.62%505.17M | 58.61%323.16M | 31.01%148.37M | 8.22%544.42M | -14.10%351.75M | -25.12%203.75M | -20.22%113.25M | -17.34%503.08M |
Staff behalf paid | 17.71%74.21M | 42.98%269.77M | 44.26%190.29M | 40.89%130.01M | 24.41%63.05M | 9.36%188.68M | 21.10%131.91M | -4.66%92.28M | -6.33%50.68M | 1.12%172.53M |
All taxes paid | 91.14%7.11M | 41.98%20.74M | 69.16%14.01M | -17.33%7.2M | -14.95%3.72M | -3.47%14.61M | -31.92%8.28M | 24.16%8.71M | -8.05%4.37M | 49.73%15.13M |
Cash paid relating to other operating activities | 3.04%28.83M | 0.57%106.54M | 19.21%78.85M | 13.38%50.65M | -5.17%27.98M | 17.05%105.93M | -17.50%66.14M | -3.19%44.67M | 4.55%29.5M | -28.63%90.5M |
Cash outflows from operating activities | 58.35%384.98M | 22.33%1.04B | 41.26%788.32M | 46.25%511.02M | 22.91%243.12M | 9.27%853.64M | -8.62%558.08M | -17.21%349.41M | -13.63%197.8M | -14.72%781.24M |
Net cash flows from operating activities | -53.22%-48.62M | -8.72%237.35M | -56.84%77.9M | -80.29%27.39M | -144.31%-31.73M | 149.05%260.02M | 826.71%180.51M | 788.66%138.94M | 266.98%71.62M | 67.84%104.4M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | 326.54%230.63M | 39.71%966.03M | 26.55%629.42M | -31.62%206.39M | -61.62%54.07M | 586.46%691.44M | 517.67%497.36M | 902.36%301.84M | 388,811.87%140.87M | -10.14%100.73M |
Cash received from returns on investments | --2.1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --690 | -38.78%82K | -88.06%8.38K | ---- | ---- | -63.06%133.94K | -79.52%70.23K | -86.27%47.03K | ---- | 16,829.34%362.56K |
Cash received relating to other investing activities | ---- | --109.61K | --23.02K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash inflows from investing activities | 330.43%232.73M | 39.71%966.22M | 26.54%629.45M | -31.63%206.39M | -61.62%54.07M | 584.13%691.57M | 515.14%497.43M | 891.24%301.89M | 388,811.87%140.87M | -9.82%101.09M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | -42.78%37.88M | -33.46%204.79M | -37.05%147.16M | -31.62%83.6M | -12.19%66.21M | -32.35%307.76M | -20.02%233.78M | -48.38%122.26M | -13.07%75.4M | 5.23%454.97M |
Cash paid to acquire investments | 69.91%192M | 72.89%1.23B | 103.18%936.67M | -2.06%303.6M | 2.73%113M | 282.71%711M | 188.13%461M | 210.00%310M | 266.67%110M | 271.56%185.78M |
Net cash paid to acquire subsidiaries and other business units | ---- | --52.58M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | -97.96%390.01K | ---- | ---- | ---- | --19.13M |
Cash outflows from investing activities | 28.28%229.88M | 45.86%1.49B | 56.00%1.08B | -10.42%387.2M | -3.34%179.21M | 54.45%1.02B | 47.38%694.78M | 21.44%432.26M | 58.82%185.4M | 36.80%659.88M |
Net cash flows from investing activities | 102.28%2.85M | -58.85%-520.37M | -130.24%-454.38M | -38.69%-180.81M | -181.04%-125.14M | 41.38%-327.58M | 49.47%-197.35M | 59.95%-130.37M | 61.84%-44.53M | -50.91%-558.79M |
Financing cash flow | ||||||||||
Cash received from capital contributions | ---- | --383.1M | --383.1M | --383.1M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from borrowing | -56.25%35M | -57.89%80M | -46.67%80M | -46.67%80M | -46.67%80M | -11.92%190M | 0.00%150M | 0.00%150M | 200.00%150M | -48.58%215.71M |
Cash inflows from financing activities | -56.25%35M | 143.74%463.1M | 208.73%463.1M | 208.73%463.1M | -46.67%80M | -11.92%190M | 0.00%150M | 0.00%150M | 200.00%150M | -48.58%215.71M |
Borrowing repayment | --4M | -50.35%61.14M | -90.58%6.66M | 304.36%2.66M | ---- | 1,131.42%123.14M | 606.57%70.66M | --657.12K | ---- | 0.00%10M |
Dividend interest payment | -28.45%4.8M | 8.34%39.93M | 8.33%31.55M | 17.97%28.46M | -6.81%6.71M | 47.05%36.85M | 54.99%29.13M | 134.48%24.13M | 43.50%7.2M | 93.34%25.06M |
Cash payments relating to other financing activities | -100.00%177.83 | 495.87%20.03M | 3,354.15%20.62M | 3,312.10%20.37M | --15.34M | 11.40%3.36M | -20.61%596.96K | -20.61%596.96K | ---- | -48.33%3.02M |
Cash outflows from financing activities | -60.08%8.8M | -25.87%121.1M | -41.39%58.83M | 102.87%51.49M | 206.22%22.05M | 328.99%163.36M | 239.75%100.38M | 129.87%25.38M | 39.27%7.2M | 32.21%38.08M |
Net cash flows from financing activities | -54.79%26.2M | 1,183.65%342M | 714.76%404.27M | 230.29%411.61M | -59.42%57.95M | -85.00%26.64M | -58.81%49.62M | -10.32%124.62M | 218.54%142.8M | -54.53%177.63M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | 25.81%2.17M | 168.30%8.73M | 180.56%5.04M | 131.96%4.97M | 156.71%1.73M | -66.38%3.25M | -83.64%1.8M | -67.74%2.14M | -584.62%-3.05M | 532.05%9.67M |
Net increase in cash and cash equivalents | 82.10%-17.4M | 279.75%67.72M | -5.02%32.84M | 94.45%263.16M | -158.25%-97.19M | 85.90%-37.67M | 112.18%34.57M | 167.65%135.33M | 244.83%166.85M | -432.22%-267.08M |
Add:Begin period cash and cash equivalents | 20.15%403.77M | -10.08%336.06M | -10.08%336.06M | -10.08%336.06M | -10.08%336.06M | -41.68%373.73M | -41.68%373.73M | -41.68%373.73M | -41.68%373.72M | 14.35%640.81M |
End period cash equivalent | 61.75%386.37M | 20.15%403.77M | -9.65%368.89M | 17.71%599.22M | -55.81%238.86M | -10.08%336.06M | 14.42%408.3M | 15.50%509.06M | 2.85%540.57M | -41.68%373.73M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Hexin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Hexin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Hexin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.